AU2002221841A1 - Polynucleotide and polypeptide sequences of human purple acid phosphate - Google Patents

Polynucleotide and polypeptide sequences of human purple acid phosphate

Info

Publication number
AU2002221841A1
AU2002221841A1 AU2002221841A AU2184102A AU2002221841A1 AU 2002221841 A1 AU2002221841 A1 AU 2002221841A1 AU 2002221841 A AU2002221841 A AU 2002221841A AU 2184102 A AU2184102 A AU 2184102A AU 2002221841 A1 AU2002221841 A1 AU 2002221841A1
Authority
AU
Australia
Prior art keywords
polynucleotide
human
polypeptide sequences
acid phosphate
purple acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002221841A
Inventor
Alex Smolyar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of AU2002221841A1 publication Critical patent/AU2002221841A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2002221841A 2000-11-14 2001-11-12 Polynucleotide and polypeptide sequences of human purple acid phosphate Abandoned AU2002221841A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US24771300P 2000-11-14 2000-11-14
US60/247,713 2000-11-14
US30513401P 2001-07-16 2001-07-16
US60/305,134 2001-07-16
PCT/EP2001/013065 WO2002040684A2 (en) 2000-11-14 2001-11-12 Polynucleotide and polypeptide sequences of human purple acid phosphate

Publications (1)

Publication Number Publication Date
AU2002221841A1 true AU2002221841A1 (en) 2002-05-27

Family

ID=26938857

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002221841A Abandoned AU2002221841A1 (en) 2000-11-14 2001-11-12 Polynucleotide and polypeptide sequences of human purple acid phosphate

Country Status (2)

Country Link
AU (1) AU2002221841A1 (en)
WO (1) WO2002040684A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001285133A1 (en) 2000-08-22 2002-03-04 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services SH2 domain binding inhibitors
US7425537B2 (en) 2000-08-22 2008-09-16 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services SH2 domain binding inhibitors
WO2008100220A1 (en) * 2007-02-14 2008-08-21 Karolinska Innovations Ab Compositions for increasing body weight, use and methods

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9803959D0 (en) * 1998-11-19 1998-11-19 Pharmacia & Upjohn Ab inhibitors
EP1179065A2 (en) * 1999-05-14 2002-02-13 Incyte Genomics, Inc. Full-length molecules expressed in human tissues
EP1074617A3 (en) * 1999-07-29 2004-04-21 Research Association for Biotechnology Primers for synthesising full-length cDNA and their use

Also Published As

Publication number Publication date
WO2002040684A3 (en) 2002-11-07
WO2002040684A2 (en) 2002-05-23

Similar Documents

Publication Publication Date Title
AU2002230831A1 (en) Compositions of human proteins and method of use thereof
IL153824A0 (en) Method and kit for diagnosis of diseases
PL350822A1 (en) Disposable wiper-cloth and method of making same
AU2001253411A1 (en) Medical dressing assembly and associated method of using the same
AU2569599A (en) Cells or tissues with increased protein factors and methods of making and using same
AU3985200A (en) Functionally improved battery and method of making same
AU6059100A (en) Thermal and ph stable protein thickening agent and method of making the same
AU6340600A (en) Telomerase inhibitors and methods of their use
PL350826A1 (en) Disposable wiper-cloth and method of making same
AU2002243446A1 (en) Method of making hydrofluorocarbons and hydrochlorofluorocarbons
AU5800399A (en) Polish composition and method of use
PL342500A1 (en) Derivatives of pyrolydin-3-carboxylic acid and their application as endothelin antagonists
AU2002227279A1 (en) Polynucleotide and polypeptide sequences of putative transporters and ion channells
AU6585498A (en) Novel uncoupling protein and methods of use
AU5836498A (en) N-acyl-hydroxyamino acid esters and their use
AU7222598A (en) Treatment of depression and anxiety using docosahexaenoic acid or natural antioxidants
AU2002221755A1 (en) Nucleotide and polypeptide sequence of human lysosomal acid lipase
AU6450398A (en) Sr-bi regulatory sequences and therapeutic methods of use
AU2002365202A1 (en) Synthetic genes for malarial proteins and methods of use
AU2002221841A1 (en) Polynucleotide and polypeptide sequences of human purple acid phosphate
EP1220896A4 (en) Novel human lipase proteins, nucleic acids encoding them, and uses of both of these
IL149506A0 (en) Human heparanase-related polypeptide and nucleic acid
PL341205A1 (en) Method of obtaining l-dihydroorotic acid and application thereof
AU3964499A (en) Agouti-related protein analogs and methods of use
AU3996799A (en) Alpha amino acid composition and method for the treatment of skin